Moxalactam sodium saltMoxalactam sodium salt
MedChemExpress (MCE)
HY-B1484
64953-12-4
Latamoxef sodium
Lamoxactam sodium
LY-127935 sodium
97.39%
4°C, stored under nitrogen, away from moisture *In solvent : -80°C, 6 months
-20°C, 1 month (stored under nitrogen, away from moisture)
Room temperature in continental US
may vary elsewhere.
Moxalactam (Latamoxef) sodium salt is a synthetic oxa-β-lactam antibiotic. Moxalactam sodium salt has a broad spectrum of activity against Gram-positive and Gram-negative aerobic and anaerobic bacteria. Moxalactam sodium salt inhibits production of β-lactamases.
Moxalactam (Latamoxef) inhibits 90% of strains of Escherichia coli, Klebsiella species, Proteus species, Morganella morganii, Neisseria gonorrhoeae, Neisseria meningitidis, Haemophilus influenzae and Salmonella species, including strains which are resistant to Cephalothin (HY-B1275A) and Gentamicin (HY-A0276A) at concentrations of less than 1 μg/mL[1]. Moxalactam exhibits moderate activity against P. aeruginosa and is usually active against other species of Pseudomonas, Acinetobacter species are usually resistant to Moxalactam[1]. Moxalactam has marked stability in vitro against a variety of β-lactamases, including that produced by B. fragilis, inhibits production of β-lactamases and does not induce class I β-lactamase[1].
Moxalactam (Latamoxef) (0-7.4 mg/mouse
s.c.
once) is effective against bacterial infections in mice[2].
β-lactam
| | | |
| | | | | |
[1]. Carmine AA, et al. Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs. 1983 Oct
26(4):279-333. [Content Brief]
[2]. Goto S. In vitro and in vivo antibacterial activity of moxalactam, an oxa-β-lactam antibiotic. Clinical Infectious Diseases, 1982, 4(Supplement_3): S501-S510.